(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.

<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Ennaid’s Harrison on Developing Cure for the Zika Virus (Audio)

Ennaid's Harrison on Developing Cure for the Zika Virus (Audio)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/8a97a5ea-e70f-4c6a-a7a5-ae3c009127f3/transcript

Advertisement